$DFTX Cashflow Statement | Understand Stock

$DFTX

$35.50 -$0.17 (0.48%) Live

$DFTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Directors' deferred share units expense
Change in fair value on directors' deferred share units ("DDSU")
Amortization of intangible assets
Change in fair value of 2022 USD Financing Warrants
Gain on extinguishment of contribution payable
Accretion of discounts and premiums on investments, net
Unrealized foreign exchange
Non-cash Lease Expense
Issuance costs on 2022 USD Financing Warrants
Amortization of debt issuance costs
Issuance costs on liability classified warrants
Other non-cash adjustments
Changes in operating assets and liabilities:
Prepaid and other current assets
Other noncurrent assets
Accounts payable
Accrued expenses
Deferred tax liability
Contribution payable
Other liabilities, long-term
Net cash used in operating activities

Cash flows from investing activities
Acquisition, net of cash acquired
Purchases of investments
Maturity of investments
Net cash used in investing activities

Cash flows from financing activities
Proceeds from the August Offering
Payment of issuance costs from the August Offering
Proceeds from the March Offering and Private Placement
Proceeds from equity offerings
Payment of equity offering costs
Proceeds from credit facility
Repayment of credit facility
Payment of credit facility issuance costs
Proceeds from the 2022 ATM net of issuance costs
Proceeds from issuance of 2022 USD Financing Warrants
Payment of 2022 USD Financing Warrants issuance costs
Payment of deferred financing fees related to 2024 At-the-Market
Payment of deferred financing fees related to 2024 ATM
Proceeds from exercise of 2022 USD Financing Warrants
Proceeds from exercise of options
Proceeds from issuance of common shares under ESPP
Withholding taxes paid on vested RSUs
Net cash provided by financing activities

Effect of exchange rate changes on cash
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of Period
Cash and cash equivalents, end of period
Supplemental Cash Flow Information
Cash paid for interest and final payment for credit facility
Supplemental Noncash Disclosures
Conversion of 2022 USD Financing Warrants to common shares upon exercise of warrants
Reclass of deferred financing fees related to 2022 At-the-Market to additional paid-in capital
Issuance of common shares upon conversion of loan principal
Issuance of common shares upon conversion of term loan principal
Lease liabilities arising from obtaining right-of-use assets
Unpaid issuance costs for credit facility
Proceeds from issuance of common shares under the at-the-market offering program in prepaid and other current assets
Amortization of deferred financing costs for 2024 ATM
Offering issuance costs in accrued liabilities
Reclass of Deferred Financing Fees to Additional Paid-In Capital

Comments